ABO & Rhesus (Rh D) Blood Group Typing by Forward & Reverse Hemagglutination
๐ฌ Principle & Theoretical Background
The human ABO blood group system was discovered by Karl Landsteiner in 1900, establishing the foundation of safe blood transfusion medicine. ABO antigens (agglutinogens) are carbohydrate oligosaccharide chains covalently linked to glycoproteins and glycosphingolipids on the erythrocyte plasma membrane:
- H-Antigen Precursor: The basic oligosaccharide precursor terminates in L-fucose attached by an $alpha(1to 2)$ fucosyltransferase (encoded by the *FUT1* gene).
- A-Antigen: The *A* allele encodes an $alpha(1to 3)$-N-acetylgalactosaminyltransferase that attaches N-acetylgalactosamine (GalNAc) to the terminal galactose of the H antigen.
- B-Antigen: The *B* allele encodes an $alpha(1to 3)$-galactosyltransferase that attaches D-galactose to the H antigen.
- O-Phenotype: The *O* allele contains a single base deletion ($Delta 261text{G}$) causing a frameshift and producing an inactive enzyme; the unextended H antigen remains unaltered.
Landsteiner’s Law:
1. If an agglutinogen (antigen) is present on an individual’s red blood cells, the corresponding isoantibody (agglutinin) must be absent from plasma.
2. If an agglutinogen is absent from red blood cells, the corresponding isoantibody must be present in plasma (naturally occurring IgM antibodies produced in response to gut bacterial microbiota).
Rhesus (Rh) System: The Rh blood group system depends on transmembrane protein antigens encoded by the *RHD* and *RHCE* genes on Chromosome 1. The D antigen is the most clinically immunogenic. Individuals possessing the D antigen are classified as Rh-positive ($text{Rh}^+$); individuals lacking the D antigen (often due to homozygous deletion of the *RHD* gene) are Rh-negative ($text{Rh}^-$). Unlike ABO antibodies, anti-D antibodies are not naturally occurring; they are acquired IgG antibodies generated following exposure through transfusion or feto-maternal hemorrhage (causing hemolytic disease of the fetus and newborn, HDFN / erythroblastosis fetalis).
๐ Step-by-Step Slide Grouping Protocol
- Tile Preparation: Clean a dry white glazed porcelain tile or three-well glass slide. Label the three reaction zones as “Anti-A”, “Anti-B”, and “Anti-D”.
- Antisera Dispensing: Place one drop ($~50,mutext{L}$) of monoclonal Anti-A reagent (blue dye) in the first well, one drop of Anti-B reagent (yellow dye) in the second well, and one drop of Anti-D reagent (clear) in the third well.
- Blood Sample Addition: Clean the subject’s fingertip with an alcohol swab, allow to air-dry, and puncture with a sterile single-use disposable lancet. Wipe away the first drop of blood. Add one drop of whole blood (or a $5%$ RBC suspension in saline) adjacent to each antiserum drop.
- Mixing & Rocking: Using separate clean applicator sticks for each circle (never reuse sticks to prevent cross-contamination), mix the blood and reagent thoroughly across a $20,text{mm}$ area.
- Reading Agglutination: Rock the tile gently back and forth for exactly 2 minutes. Observe under strong incident light for visible brick-red clumping/lattice formation (hemagglutination) versus smooth uniform suspension.
๐ Blood Group Phenotype Interpretation Matrix
| Anti-A (Blue) | Anti-B (Yellow) | Anti-D (Clear) | RBC Antigen(s) | Serum Antibody | Resulting Blood Group |
|---|---|---|---|---|---|
| Agglutination (+) | No Clumping (-) | Agglutination (+) | A and D | Anti-B | A Positive (Aโบ) |
| Agglutination (+) | No Clumping (-) | No Clumping (-) | A only | Anti-B | A Negative (Aโป) |
| No Clumping (-) | Agglutination (+) | Agglutination (+) | B and D | Anti-A | B Positive (Bโบ) |
| No Clumping (-) | Agglutination (+) | No Clumping (-) | B only | Anti-A | B Negative (Bโป) |
| Agglutination (+) | Agglutination (+) | Agglutination (+) | A, B, and D | None | AB Positive (ABโบ) |
| Agglutination (+) | Agglutination (+) | No Clumping (-) | A and B | None | AB Negative (ABโป) |
| No Clumping (-) | No Clumping (-) | Agglutination (+) | D only | Anti-A and Anti-B | O Positive (Oโบ) |
| No Clumping (-) | No Clumping (-) | No Clumping (-) | None | Anti-A and Anti-B | O Negative (Oโป) |